0.10p+0.00 (+2.15%)28 Mar 2024, 11:53
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Deltex Medical Group PLC Fundamentals

Company NameDeltex Medical Group PLCLast Updated2024-03-28
IndustryMedical DevicesSectorHealthcare
Shares in Issue1.896 bnMarket Cap£1.99 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.3950Debt Equity Ratio0.5847
Asset Equity Ratio3.2304Cash Equity Ratio0.0663
Quick Ratio0.1944Current Ratio0.54
Price To Book Value0.9964ROCE0

Deltex Medical Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Deltex Medical Group PLC Company Financials

Assets20222021
Tangible Assets£269,000.00£264,000.00
Intangible Assets£3.77 m£3.13 m
Investments00
Total Fixed Assets£4.20 m£3.56 m
Stocks£821,000.00£796,000.00
Debtors£491,000.00£458,000.00
Cash & Equivalents£471,000.00£413,000.00
Other Assets00
Total Assets£6.18 m£5.39 m
Liabilities20222021
Creditors within 1 year£2.64 m£2.18 m
Creditors after 1 year£1.31 m£1.31 m
Other Liabilities00
Total Liabilities£3.95 m£3.49 m
Net assets£2.23 m£1.90 m
Equity20222021
Called up share capital£6.99 m£5.85 m
Share Premium£51.15 m£50.98 m
Profit / Loss-£1.15 m-£978,000.00
Other Equity£2.35 m£2.03 m
Preference & Minorities-£121,000.00-£125,000.00
Total Capital Employed£2.23 m£1.90 m
Ratios20222021
Debt Ratio£0.35£0.38
Debt-to-Equity£0.53£0.62
Assets / Equity3.23043.2304
Cash / Equity0.06630.0663
EPS£-0.00£-0.00
Cash Flow20222021
Cash from operating activities-£606,000.00-£291,000.00
Cashflow before financing£807,000.00£211,000.00
Increase in Cash£63,000.00-£433,000.00
Income20222021
Turnover£2.48 m£2.26 m
Cost of sales£643,000.00£684,000.00
Gross Profit£1.84 m£1.57 m
Operating Profit-£947,000.00-£805,000.00
Pre-Tax profit-£1.15 m-£978,000.00

Deltex Medical Group PLC Company Background

SectorHealthcare
ActivitiesDeltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Dopplertechnology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.
Latest Interim Date18 Sep 2023
Latest Fiscal Year End Date29 Mar 2024

Deltex Medical Group PLC Directors

AppointedNamePosition
2020-12-31Professor Sir. Duncan Kirkbride Nichol, CBENon-Executive Director
2018-06-13Mr. Ewan Alastair PhillipsExecutive Director,Chief Executive Officer
2024-01-18Mr. Nigel John KeenNon-Executive Director,Chairman
2014-05-07Dr. Edwin SnapeNon-Executive Director,Vice Chairman
2023-12-04Mr. Julian Cazalet Non-Executive Director
2006-11-23Mr. Peter Thomas Smedvig BA,MBANon-Executive Director
2006-11-23Dr. George Flouty, M.D.Non-Executive Director
2011-08-09Mr. Andy Hill MBA,BScExecutive Director,Chief Executive Officer
2015-04-02Mr. Paul MitchellExecutive Director,Finance Director
2023-12-04Professor Timothy Norris IrishNon-Executive Director
2023-12-04Mr. Mark Alexander WippellNon-Executive Director
2024-01-18Mr. Christopher Michael JonesNon-Executive Director,Senior Independent Director
2019-10-07Mr. Jonathan David ShawExecutive Director,Group Finance Director and Company Secretary
2023-07-14Mr. Andrew Jonathan MearsExecutive Director,Chief Executive Officer
2022-04-20Mr. David Philip Moorhouse Executive Director,Finance Director and Company Secretary
2023-08-02Ms. Natalie Emilia WettlerExecutive Director,Group Finance Director and Company Secretary

Deltex Medical Group PLC Contact Details

Company NameDeltex Medical Group PLC
AddressTerminus Road, Chichester, PO19 8TX
Telephone+44 1243774837
Websitehttps://www.deltexmedical.com/

Deltex Medical Group PLC Advisors

AuditorPricewaterhouseCoopers LLP
Phone+44 2380330077
Fax+44 2380202244
Financial PR AdviserIFC Advisory Ltd
Phone+44 2030538671
StockbrokerZeus Capital Ltd
Phone+44 2038295000
SolicitorLaytons
Phone(020) 7842 8000
Fax(020) 7842 8080
StockbrokerArden Partners PLC
Phone+44 2076145900
Fax+44 02076145901
SolicitorEversheds Sutherland
Phone+44 2079194500
Fax+44 2079194919
BankRoyal Bank of Scotland PLC
Nominated AdviserArden Partners PLC
Phone+44 2076145900
Fax+44 2076145901
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342